MENU
+Compare
PODD
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$275.81
Change
+$2.95 (+1.08%)
Capitalization
11.75B

PODD Insulet Corp Forecast, Technical & Fundamental Analysis

a manufacturer of insulin infusion systems

PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PODD with price predictions
Jan 14, 2025

PODD in upward trend: price rose above 50-day moving average on January 03, 2025

PODD moved above its 50-day moving average on January 03, 2025 date and that indicates a change from a downward trend to an upward trend. In of 48 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 08, 2025. You may want to consider a long position or call options on PODD as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PODD just turned positive on January 08, 2025. Looking at past instances where PODD's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PODD advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PODD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. PODD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.051) is normal, around the industry mean (23.475). P/E Ratio (57.167) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (3.019) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (7.294) is also within normal values, averaging (41.274).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PODD is expected to report earnings to rise 14.44% to $1.03 per share on February 20

Insulet Corp PODD Stock Earnings Reports
Q4'24
Est.
$1.03
Q3'24
Beat
by $0.12
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.17
Q4'23
Beat
by $0.75
The last earnings report on November 07 showed earnings per share of 89 cents, beating the estimate of 77 cents. With 554.11K shares outstanding, the current market capitalization sits at 11.75B.
A.I. Advisor
published General Information

General Information

a manufacturer of insulin infusion systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
100 Nagog Park
Phone
+1 978 600-7000
Employees
3000
Web
https://www.insulet.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

PODD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PODD has been loosely correlated with MDT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PODD
1D Price
Change %
PODD100%
+1.08%
MDT - PODD
39%
Loosely correlated
+1.06%
IRMD - PODD
37%
Loosely correlated
+1.39%
XRAY - PODD
37%
Loosely correlated
+1.79%
ABT - PODD
36%
Loosely correlated
-0.38%
RVTY - PODD
35%
Loosely correlated
-0.90%
More